Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Draelos

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2024
Top weapons in skin aging and actives to target the consequences of skin cell senescenceZ Draelos, P Bogdanowicz, J-H Saurat
Cutis|August 14, 2001
Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trialJ Leyden, N Lowe, L Kakita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2010
Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert GroupB E Elewski, Z Draelos, B Dréno, et al.
The British Journal of Dermatology|May 27, 2009
Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patientsH P M Gollnick, Z Draelos, M J Glenn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2019
Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acneU Blume-Peytavi, J Fowler, L Kemény, et al.
The British Journal of Dermatology|February 5, 2021
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)D Thaci, S Piaserico, R B Warren, et al.
Journal of the American Academy of Dermatology|June 12, 1999
Finasteride in the treatment of men with frontal male pattern hair lossJ Leyden, F Dunlap, B Miller, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2024
Top weapons in skin aging and actives to target the consequences of skin cell senescenceZ Draelos, P Bogdanowicz, J-H Saurat
Cutis|August 14, 2001
Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trialJ Leyden, N Lowe, L Kakita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2010
Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert GroupB E Elewski, Z Draelos, B Dréno, et al.
The British Journal of Dermatology|May 27, 2009
Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patientsH P M Gollnick, Z Draelos, M J Glenn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2019
Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acneU Blume-Peytavi, J Fowler, L Kemény, et al.
The British Journal of Dermatology|February 5, 2021
Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)D Thaci, S Piaserico, R B Warren, et al.
Journal of the American Academy of Dermatology|June 12, 1999
Finasteride in the treatment of men with frontal male pattern hair lossJ Leyden, F Dunlap, B Miller, et al.
Pageof 1